Micrometer‐scale tPA beads amplify plasmin generation for enhanced thrombolytic therapy
Bioengineering & Translational MedicineRapid restoration of blood flow is critical in treating acute ischemic stroke. Current thrombolytic therapies using tissue plasminogen activator (tPA) are limited by low recanalization rates and risks of off‐target bleeding.
Matthew J. Osmond +6 more
doaj +1 more source
Requirement of heparin for arterial and venous thrombolysis with recombinant tissue-type plasminogen activator [PDF]
, 1991 HJ Rapold +4 more
openalex +1 more source
Prior Statin Use May Be Associated With Improved Stroke Outcome After Tissue Plasminogen Activator [PDF]
, 2007 José Álvarez‐Sabín +7 more
openalex +1 more source
MO266: Deficiency of Urokinase-Type Plasminogen Activator Exacerbates CBSA-Induced Membranous Nephropathy in Mice [PDF]
, 2022 Tzu‐Ming Jao +3 more
openalex +1 more source
Treatment of Hepatic Venocclusive Disease With Recombinant Human Tissue Plasminogen Activator and Heparin in 42 Marrow Transplant Patients [PDF]
, 1997 Scott I. Bearman +3 more
openalex +1 more source
Tissue Plasminogen Activator–Mediated Fibrinolysis Protects against Axonal Degeneration and Demyelination after Sciatic Nerve Injury [PDF]
, 2000 Katerina Akassoglou +3 more
openalex +1 more source
Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia [PDF]
, 2009 Sophie Gautier +4 more
openalex +1 more source